Fulgent Genetics FLGT
NASDAQ FLGT
$21.69 -0.16 (-0.73%)
At close: Sep 18, 2026 · 4:00 PM EDT

Fulgent Genetics (FLGT) Acquisitions (2021 - 2026)

Fulgent Genetics' (FLGT) quarterly Acquisitions came in at $55.6 million in Q1 2026, up 1571.97% quarter-over-quarter from -$3.8 million in Q3 2025.

Analysis

Fulgent Genetics (FLGT) Acquisitions (2021 - 2026) Analysis & Trends

Fulgent Genetics has disclosed Acquisitions across 4 years of filings, most recently posting $55.6 million for Q1 2026.

  • In Q1 2026, Acquisitions changed N/A year-over-year to $55.6 million; the TTM figure through Jun 2026 stood at $51.8 million (up 48.3% YoY), while the FY2025 annual figure was -$3.8 million, changed N/A from the prior year.
  • Acquisitions came in at $55.6 million for Q1 2026 at Fulgent Genetics, up from -$3.8 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $55.6 million in Q1 2026 to a low of -$3.8 million in Q3 2025.
  • Average Acquisitions over 3 years is $28.9 million, with a median of $34.9 million recorded in 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn -
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 225.70 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn -
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn -
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn -
10 Fulgent Genetics 596.80 Mn 334.14 Mn 25.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 55.57 Mn
Sep 30, 2025 -3.78 Mn
Dec 31, 2022 34.92 Mn
Sep 30, 2021 43.36 Mn